1131324 - Genomic Health Inc - SEC Form 4 Insider Trading Screener

Services - Health Services - Medical Laboratories - GHDX (1131324)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S4+0-2+4+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

A
2018-02-15
GHDXPla FredericChief Bus, Prod Dev OfficerF - Tax$32.66-3,60038,712-9%-$117,576
2018-02-15
GHDXRadford Jason W.GCF - Tax$32.66-2,06538,820-5%-$67,443
2018-02-15
GHDXMcEachron KimChief People OfficerF - Tax$32.66-2,22133,727-6%-$72,538
2018-02-15
GHDXLeber LauraChief Communication OfficerF - Tax$32.66-1,99919,905-9%-$65,287
2018-02-15
GHDXFebbo Phillip G.Chief Medical OfficerF - Tax$32.66-2,80126,329-10%-$91,481
2018-02-15
GHDXVaughn James JChief Commercial OfficerF - Tax$32.66-3,11531,152-9%-$101,736
2018-02-15
GHDXPla FredericChief Bus, Prod Dev OfficerF - Tax$32.66-3,60038,712-9%-$117,576
2018-02-15
GHDXShak StevenChief Scientific OfficerF - Tax$32.66-2,825335,916-1%-$92,265
2018-02-15
GHDXCole G BradleyCOOF - Tax$32.66-3,18244,754-7%-$103,924
2018-02-15
GHDXPopovits Kimberly JPres, CEOF - Tax$32.66-6,232326,052-2%-$203,537
D
2018-02-14
GHDXPopovits Kimberly JPres, CEOM - OptEx$17.18+10,000332,284+3%+$171,800
D
2018-02-14
GHDXPopovits Kimberly JPres, CEOS - Sale+OE$32.93-10,000332,284-3%-$329,336
D
2018-01-31
GHDXRadford Jason W.GCA - Grant$0.00+15,06040,885+58%+$0
D
2018-01-31
GHDXMcEachron KimChief People OfficerA - Grant$0.00+7,57035,948+27%+$0
D
2018-01-31
GHDXLeber LauraChief Communication OfficerA - Grant$0.00+6,15021,904+39%+$0
D
2018-01-31
GHDXFebbo Phillip G.Chief Medical OfficerA - Grant$0.00+11,33029,130+64%+$0
D
2018-01-31
GHDXVaughn James JChief Commercial OfficerA - Grant$0.00+6,79034,267+25%+$0
D
2018-01-31
GHDXShak StevenChief Scientific OfficerA - Grant$0.00+6,030338,741+2%+$0
D
2018-01-31
GHDXPla FredericChief Bus, Prod Dev OfficerA - Grant$0.00+9,79042,312+30%+$0
D
2018-01-31
GHDXCole G BradleyCOOA - Grant$0.00+7,59047,936+19%+$0
D
2018-01-31
GHDXPopovits Kimberly JPres, CEOA - Grant$0.00+23,930332,284+8%+$0
D
2018-01-16
GHDXPopovits Kimberly JPres, CEOM - OptEx$17.18+10,000308,354+3%+$171,800
D
2018-01-16
GHDXPopovits Kimberly JPres, CEOS - Sale+OE$34.99-10,000308,354-3%-$349,885
D
2018-01-09
GHDXCole G BradleyCOOM - OptEx$17.33+5,00040,346+14%+$86,650
D
2018-01-09
GHDXCole G BradleyCOOS - Sale+OE$35.51-5,00040,346-11%-$177,566
D
2018-01-02
GHDXVaughn James JChief Commercial OfficerM - OptEx$17.33+2,16927,477+9%+$37,589
D
2018-01-02
GHDXVaughn James JChief Commercial OfficerS - Sale+OE$34.09-3,00427,477-10%-$102,406
2018-01-01
GHDXCohen Fred EDirA - Grant$34.20+29272,8730%+$9,986
2018-01-01
GHDXFuchs Henry JDirA - Grant$34.20+2925,518+6%+$9,986
2018-01-01
GHDXGraham Ginger LDirA - Grant$34.20+2929,739+3%+$9,986
2018-01-01
GHDXBaker Bros. Advisors LPDir, 10%A - Grant$34.20+3,504504,594+1%+$119,837
D
2017-12-19
GHDXFebbo Phillip G.Chief Medical OfficerM - OptEx$27.00+5,00017,800+39%+$135,000
D
2017-12-19
GHDXFebbo Phillip G.Chief Medical OfficerS - Sale+OE$36.99-5,33417,800-23%-$197,298
DM
2017-12-14
GHDXLeber LauraChief Communication OfficerM - OptEx$19.72+21,00015,754-400%+$414,210
DM
2017-12-14
GHDXLeber LauraChief Communication OfficerS - Sale+OE$33.29-21,00015,754-57%-$699,000
D
2017-12-14
GHDXPopovits Kimberly JPres, CEOM - OptEx$17.28+20,000308,354+7%+$345,535
D
2017-12-14
GHDXPopovits Kimberly JPres, CEOS - Sale+OE$31.50-20,000308,354-6%-$630,000
AD
2017-12-12
GHDXCole G BradleyCOOM - OptEx$17.33+5,00040,346+14%+$86,650
AD
2017-12-12
GHDXCole G BradleyCOOS - Sale+OE$29.94-5,00040,346-11%-$149,709
D
2017-12-12
GHDXCole G BradleyCOOM - OptEx$17.33+5,00039,935+14%+$86,650
D
2017-12-12
GHDXCole G BradleyCOOS - Sale+OE$29.94-5,00039,935-11%-$149,709
D
2017-11-07
GHDXCole G BradleyCOOM - OptEx$17.33+5,00039,935+14%+$86,650
D
2017-11-07
GHDXCole G BradleyCOOS - Sale+OE$31.47-5,00039,935-11%-$157,330
DM
2017-11-01
GHDXVaughn James JChief Commercial OfficerM - OptEx$17.33+4,83127,620+21%+$83,721
DM
2017-11-01
GHDXVaughn James JChief Commercial OfficerS - Sale+OE$32.57-6,99627,620-20%-$227,829
D
2017-10-10
GHDXCole G BradleyCOOM - OptEx$17.33+5,00039,935+14%+$86,650
D
2017-10-10
GHDXCole G BradleyCOOS - Sale+OE$31.93-5,00039,935-11%-$159,637
2017-10-01
GHDXFuchs Henry JDirA - Grant$32.09+3115,226+6%+$9,980
2017-10-01
GHDXCohen Fred EDirA - Grant$32.09+31172,5810%+$9,980
2017-10-01
GHDXGraham Ginger LDirA - Grant$32.09+3119,447+3%+$9,980
2017-10-01
GHDXBaker Bros. Advisors LPDir, 10%A - Grant$32.09+3,732504,010+1%+$119,760
D
2017-09-14
GHDXPopovits Kimberly JPres, CEOM - OptEx$17.33+5,000307,567+2%+$86,650
D
2017-09-14
GHDXPopovits Kimberly JPres, CEOS - Sale+OE$31.00-5,000307,567-2%-$154,989
D
2017-09-12
GHDXCole G BradleyCOOM - OptEx$17.33+5,00039,935+14%+$86,650
D
2017-09-12
GHDXCole G BradleyCOOS - Sale+OE$31.86-5,00039,935-11%-$159,288
D
2017-08-14
GHDXPopovits Kimberly JPres, CEOM - OptEx$17.33+5,000307,567+2%+$86,650
D
2017-08-14
GHDXPopovits Kimberly JPres, CEOS - Sale+OE$30.22-5,000307,567-2%-$151,111
D
2017-08-08
GHDXVaughn James JChief Commercial OfficerM - OptEx$23.31+6,50029,785+28%+$151,515
D
2017-08-08
GHDXVaughn James JChief Commercial OfficerS - Sale+OE$30.59-8,00029,785-21%-$244,724
D
2017-08-08
GHDXCole G BradleyCOOM - OptEx$17.33+5,00039,935+14%+$86,650
D
2017-08-08
GHDXCole G BradleyCOOS - Sale+OE$30.57-5,00039,935-11%-$152,846
2017-07-19
GHDXFebbo Phillip G.Chief Medical OfficerS - Sale$33.57-3,17417,800-15%-$106,538
D
2017-07-11
GHDXCole G BradleyCOOM - OptEx$17.33+5,00039,935+14%+$86,650
D
2017-07-11
GHDXCole G BradleyCOOS - Sale+OE$32.53-5,00039,935-11%-$162,667
DM
2017-07-03
GHDXPopovits Kimberly JPres, CEOM - OptEx$17.33+5,000307,567+2%+$86,650
DM
2017-07-03
GHDXPopovits Kimberly JPres, CEOS - Sale+OE$32.59-5,000307,567-2%-$162,941
2017-07-01
GHDXFuchs Henry JDirA - Grant$32.55+3074,915+7%+$9,993
2017-07-01
GHDXCohen Fred EDirA - Grant$32.55+30772,2700%+$9,993
2017-07-01
GHDXGraham Ginger LDirA - Grant$32.55+3079,136+3%+$9,993
2017-07-01
GHDXBaker Bros. Advisors LPDir, 10%A - Grant$32.55+3,684503,388+1%+$119,914
D
2017-06-23
GHDXShak StevenChief Scientific OfficerM - OptEx$23.31+5,000331,924+2%+$116,550
D
2017-06-23
GHDXShak StevenChief Scientific OfficerS - Sale+OE$33.27-5,000331,924-1%-$166,371
D
2017-06-13
GHDXCole G BradleyCOOM - OptEx$17.33+5,00039,935+14%+$86,650
D
2017-06-13
GHDXCole G BradleyCOOS - Sale+OE$31.67-5,00039,935-11%-$158,342
D
2017-06-05
GHDXPopovits Kimberly JPres, CEOG - Gift$0.00-100307,5670%-$0
D
2017-06-05
GHDXPopovits Kimberly JPres, CEOM - OptEx$17.33+5,000307,567+2%+$86,650
D
2017-06-05
GHDXPopovits Kimberly JPres, CEOS - Sale+OE$32.32-5,000307,567-2%-$161,582
D
2017-05-31
GHDXBaker Bros. Advisors LPDir, 10%M - OptEx$18.13+49,500502,774+11%+$897,435
D
2017-05-23
GHDXShak StevenChief Scientific OfficerM - OptEx$23.31+5,000331,103+2%+$116,550
D
2017-05-23
GHDXShak StevenChief Scientific OfficerS - Sale+OE$29.40-5,000331,103-1%-$146,981
D
2017-05-19
GHDXCohen Fred EDirM - OptEx$14.37+8,25071,963+13%+$118,553
D
2017-05-19
GHDXCohen Fred EDirS - Sale+OE$29.54-8,25071,963-10%-$243,745
D
2017-05-18
GHDXCohen Fred EDirM - OptEx$18.05+16,50071,963+30%+$297,743
D
2017-05-18
GHDXCohen Fred EDirS - Sale+OE$29.88-16,50071,963-19%-$493,040
D
2017-05-16
GHDXCohen Fred EDirM - OptEx$18.13+8,25071,963+13%+$149,573
D
2017-05-16
GHDXCohen Fred EDirS - Sale+OE$30.68-8,25071,963-10%-$253,102
2017-05-15
GHDXRadford Jason W.GCF - Tax$30.81-1,25324,902-5%-$38,605
D
2017-05-03
GHDXPopovits Kimberly JPres, CEOM - OptEx$17.33+5,000306,846+2%+$86,650-1-9
D
2017-05-03
GHDXPopovits Kimberly JPres, CEOS - Sale+OE$31.77-5,000306,846-2%-$158,849-1-9
D
2017-04-24
GHDXShak StevenChief Scientific OfficerM - OptEx$23.31+5,000331,103+2%+$116,55000
D
2017-04-24
GHDXShak StevenChief Scientific OfficerS - Sale+OE$31.46-5,000331,103-1%-$157,32300
DM
2017-03-20
GHDXPopovits Kimberly JPres, CEOG - Gift$0.00-1,364506,3330%-$0+1+1+7
D
2017-04-03
GHDXPopovits Kimberly JPres, CEOM - OptEx$20.80+5,000506,333+1%+$103,992+1+1+7
D
2017-04-03
GHDXPopovits Kimberly JPres, CEOS - Sale+OE$31.30-5,000506,333-1%-$156,507+1+1+7
2017-04-01
GHDXBaker Bros. Advisors LPDir, 10%A - Grant$31.49+3,804494,524+1%+$119,788-1+2+3
2017-04-01
GHDXFuchs Henry JDirA - Grant$31.49+3174,608+7%+$9,982-1+2+3
2017-04-01
GHDXCohen Fred EDirA - Grant$31.49+31771,9630%+$9,982-1+2+3
2017-04-01
GHDXGraham Ginger LDirA - Grant$31.49+3178,829+4%+$9,982-1+2+3
D
2017-03-23
GHDXShak StevenChief Scientific OfficerM - OptEx$23.31+5,000331,103+2%+$116,550+1+10
D
2017-03-23
GHDXShak StevenChief Scientific OfficerS - Sale+OE$31.26-5,000331,103-1%-$156,295+1+10

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top